Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips

Epigenetics

Volumn 8, Issue 1, 2013, Pages 34-43

  Shen, Jing ^a   Wang, Shuang ^a   Zhang, Yu Jing ^a   Wu, Hui Chen ^a   Kibriya, Muhammad G ^b   Jasmine, Farzana ^b   Ahsan, Habibul ^b   Wu, David P H ^c   Siegel, Abby B ^c   Remotti, Helen ^c   Santella, Regina M ^a  

^a Mailman School of Public Health of Columbia University ^*  (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c College of Physicians and Surgeons of Columbia University ^*  (United States)

Author keywords

450K BeadChips; Alterations; DNA methylation; Genome wide; Hepatocellular carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENDER; GENETIC ASSOCIATION; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; RISK FACTOR;

HEPATITIS C VIRUS;

EID: 84872016931     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.23062     Document Type: Article

References (38)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917; PMID:21351269; http://dx.doi. org/10.1002/ijc.25516.
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-76; PMID:17570226; http://dx.doi.org/10.1053/j.gastro.2007.04.061.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29; PMID:22237781; http://dx.doi.org/10.3322/ caac.20138.
4. Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300:455; PMID:12702868; http://dx.doi.org/10.1126/science.1083557.
5. Tischoff I, Tannapfe A. DNA methylation in hepatocellular carcinoma. World J Gastroenterol 2008; 14:1741-8; PMID:18350605; http://dx.doi.org/10.3748/ wjg.14.1741.
6. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98:288-95; PMID:21839163; http://dx.doi.org/10.1016/j. ygeno.2011.07.007.
7. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, et al. Differential methylation of tissueand cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009; 41:1350-3; PMID:19881528; http://dx.doi.org/10.1038/ng.471.
8. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178-86; PMID:19151715; http://dx.doi. org/10.1038/ng.298.
9. Ogoshi K, Hashimoto S, Nakatani Y, Qu W, Oshima K, Tokunaga K, et al. Genome-wide profiling of DNA methylation in human cancer cells. Genomics 2011; 98:280-7; PMID:21821115; http://dx.doi. org/10.1016/j.ygeno.2011.07.003.
10. Gao W, Kondo Y, Shen L, Shimizu Y, Sano T, Yamao K, et al. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis 2008; 29:1901-10; PMID:18632756; http://dx.doi.org/10.1093/carcin/ bgn170.
11. Shitani M, Sasaki S, Akutsu N, Takagi H, Suzuki H, Nojima M, et al. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. [Epub ahead of print]. Tumour Biol 2012; 33:33-40; PMID:21931992.
12. Shin SH, Kim BH, Jang JJ, Suh KS, Kang GH. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. J Korean Med Sci 2010; 25:1152-9; PMID:20676325; http:// dx.doi.org/10.3346/jkms.2010.25.8.1152.
13. Hernandez-Vargas H, Lambert MP, Le Calvez-Kelm F, Gouysse G, McKay-Chopin S, Tavtigian SV, et al. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One 2010; 5:e9749; PMID:20305825; http:// dx.doi.org/10.1371/journal.pone.0009749.
14. Ammerpohl O, Pratschke J, Schafmayer C, Haake A, Faber W, von Kampen O, et al. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 2012; 130:1319-28; PMID:21500188; http://dx.doi.org/10.1002/ ijc.26136.
15. Archer KJ, Mas VR, Maluf DG, Fisher RA. Highthroughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCVassociated hepatocellular carcinoma. Mol Genet Genomics 2010; 283:341-9; PMID:20165882; http:// dx.doi.org/10.1007/s00438-010-0522-y.
16. Shen J, Wang S, Zhang YJ, Kappil M, Wu HC, Kibriya MG, et al. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 2012; 55:1799-808; PMID:22234943; http://dx.doi.org/10.1002/ hep.25569.
17. Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, et al. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 2007; 3:2023-36; PMID:17967063; http://dx.doi.org/10.1371/journal. pgen.0030181.
18. Sandoval J, Heyn HA, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011; 6:692-702; PMID:21593595; http://dx.doi.org/10.4161/ epi.6.6.16196.
19. Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F. Evaluation of the Infinium Methylation 450K technology. Epigenomics 2011; 3:771-84; PMID:22126295; http://dx.doi. org/10.2217/epi.11.105.
20. Roessler J, Ammerpohl O, Gutwein J, Hasemeier B, Anwar SL, Kreipe HH, et al. Quantitative crossvalidation and content analysis of the 450k DNA methylation array from Illumina, Inc. BMC Res Notes 2012; 5:210; PMID:22546179; http://dx.doi. org/10.1186/1756-0500-5-210.
21. Beyan H, Down TA, Ramagopalan SV, Uvebrant K, Nilsson A, Holland ML, et al. Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans. Genome Res 2012; 22:2138-45; PMID:22919074; http://dx.doi.org/10.1101/ gr.134304.111.
22. Robinson MD, Stirzaker C, Statham AL, Coolen MW, Song JZ, Nair SS, et al. Evaluation of affinity-based genome-wide DNA methylation data: effects of CpG density, amplification bias, and copy number variation. Genome Res 2010; 20:1719-29; PMID:21045081; http://dx.doi.org/10.1101/gr.110601.110.
23. Jain S, Chen S, Chang KC, Lin YJ, Hu CT, Boldbaatar B, et al. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma. PLoS One 2012; 7:e35789; PMID:22536438; http://dx.doi. org/10.1371/journal.pone.0035789.
24. Herceg Z, Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat Res 2011; 727:55-61; PMID:21514401; http://dx.doi.org/10.1016/j. mrrev.2011.04.001.
25. Higgs MR, Lerat H, Pawlotsky JM. Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res 2010; 70:4901-11; PMID:20530689; http://dx.doi.org/10.1158/0008-5472.CAN-09-4554.
26. Ahmed R, Salama H, Fouad A, Sabry D, AbdAlah S, Kamal M. Detection of aberrant p16INK4A methylation in sera of patients with HCV-related liver diseases: An Egyptian study. Med Sci Monit 2010; 16:CR410-5; PMID:20802412.
27. Guo N, Chen R, Li Z, Liu Y, Cheng D, Zhou Q, et al. Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells. Acta Biochim Biophys Sin (Shanghai) 2011; 43:354-61; PMID:21450690; http://dx.doi.org/10.1093/abbs/ gmr021.
28. Lim JS, Park SH, Jang KL. Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation. Cancer Lett 2012; 321:154-61; PMID:22326283; http://dx.doi.org/10.1016/j.canlet.2012.01.044.
29. Ripoli M, Barbano R, Balsamo T, Piccoli C, Brunetti V, Coco M, et al. Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein. Virus Res 2011; 160:74-81; PMID:21640770; http://dx.doi.org/10.1016/j.virusres.2011.05.014.
30. Komatsu Y, Waku T, Iwasaki N, Ono W, Yamaguchi C, Yanagisawa J. Global analysis of DNA methylation in early-stage liver fibrosis. BMC Med Genomics 2012; 5:5; PMID:22281153; http://dx.doi. org/10.1186/1755-8794-5-5.
31. Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med 2009; 15:85-94; PMID:19098997; http://dx.doi.org/10.2119/molmed.2008.00110.
32. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002; 13:1929-39; PMID:12058060; http://dx.doi.org/10.1091/mbc.02-02-0023.
33. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 2007; 45:938-47; PMID:17393520; http://dx.doi.org/10.1002/hep.21622.
34. Kanai Y. Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci 2010; 101:36-45; PMID:19891661; http://dx.doi. org/10.1111/j.1349-7006.2009.01383.x.
35. Nishida N, Kudo M, Nagasaka T, Ikai I, Goel A. Characteristic pattern of DNA methylation alterations predict emergence of human hepatocellular carcinoma. Hepatology 2012; 55; http://dx.doi.org/10.1002/ hep.25706.
36. Wu J, Zhu AX. Targeting insulin-like growth factor axis in hepatocellular carcinoma. J Hematol Oncol 2011; 4:30; PMID:21729319; http://dx.doi. org/10.1186/1756-8722-4-30.
37. Kin T, Ono Y. Idiographica: a general-purpose web application to build idiograms on-demand for human, mouse and rat. Bioinformatics 2007; 23:2945-6; PMID:17893084; http://dx.doi.org/10.1093/bioinformatics/ btm455.
38. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 2002; 99:3740-5; PMID:11891299; http://dx.doi.org/10.1073/pnas.052410099.